# Global Asset Management Group, Inc.: financial statements, quarterly

GAMG · OTC · CIK 55234 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gamg.md) · [Financials](/companies/gamg/financials.md) · [Filings](/companies/gamg/filings.md) · [Insiders](/companies/gamg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gamg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [9.0 d](/filings/0001477932-24-007166.md) | [3.0 d](/filings/0001477932-25-002666.md) | [5.0](/filings/0001477932-25-003941.md) | [0.0 d](/filings/0001477932-25-005839.md) | [0.0 d](/filings/0001477932-25-008249.md) | [0.0 d](/filings/0001477932-26-002281.md) | [0.0](/filings/0001477932-26-003343.md) | [0.0](/filings/0001477932-26-005953.md) | [50.1 d](/filings/0001477932-25-008249.md) | [45.3 d](/filings/0001477932-26-002281.md) | [93.2](/filings/0001477932-26-003343.md) | [236](/filings/0001477932-26-005953.md) |
| Cost of revenue | $k | [0.0 d](/filings/0001477932-24-007166.md) | [0.0 d](/filings/0001477932-24-003865.md) | [0.0](/filings/0001477932-25-003941.md) | [0.0 d](/filings/0001477932-24-004867.md) | [0.0 d](/filings/0001477932-24-007166.md) | [0.0 d](/filings/0001477932-26-002281.md) | [0.0](/filings/0001477932-26-003343.md) | [0.0](/filings/0001477932-26-005953.md) | [7.3 d](/filings/0001477932-25-008249.md) | [(5.4) d](/filings/0001477932-26-002281.md) | [0.0](/filings/0001477932-26-003343.md) | [0.0](/filings/0001477932-26-005953.md) |
| Gross profit | $k | [9.0 d](/filings/0001477932-24-007166.md) | [3.0 d](/filings/0001477932-25-002666.md) | [5.0](/filings/0001477932-25-003941.md) | [0.0 d](/filings/0001477932-25-005839.md) | [0.0 d](/filings/0001477932-25-008249.md) | [0.0 d](/filings/0001477932-26-002281.md) | [0.0](/filings/0001477932-26-003343.md) | [0.0](/filings/0001477932-26-005953.md) | [42.8 d](/filings/0001477932-25-008249.md) | [50.7 d](/filings/0001477932-26-002281.md) | [93.2](/filings/0001477932-26-003343.md) | [236](/filings/0001477932-26-005953.md) |
| Research and development | $k | [1.1 d](/filings/0001477932-23-007965.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $k | [(96.2) d](/filings/0001477932-24-007166.md) | [(46.1) d](/filings/0001477932-25-002666.md) | [(65.7)](/filings/0001477932-25-003941.md) | [(128) d](/filings/0001477932-25-005839.md) | [(53.5) d](/filings/0001477932-25-008249.md) | [(44.6) d](/filings/0001477932-26-002281.md) | [(0.8)](/filings/0001477932-26-003343.md) | [(9.3)](/filings/0001477932-26-005953.md) | [(2.3) d](/filings/0001477932-25-008249.md) | [(96.3) d](/filings/0001477932-26-002281.md) | [(377)](/filings/0001477932-26-003343.md) | [(736)](/filings/0001477932-26-005953.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(82.4) d](/filings/0001477932-24-007166.md) | [(41.5) d](/filings/0001477932-25-002666.md) | [(81.4)](/filings/0001477932-25-003941.md) | [(128) d](/filings/0001477932-25-005839.md) | [(82.5) d](/filings/0001477932-25-008249.md) | [(44.6) d](/filings/0001477932-26-002281.md) | [(45.8)](/filings/0001477932-26-003343.md) | [(9.3)](/filings/0001477932-26-005953.md) | [(2.5) d](/filings/0001477932-25-008249.md) | [(97.1) d](/filings/0001477932-26-005953.md) | [(377)](/filings/0001477932-26-003343.md) | [(736)](/filings/0001477932-26-005953.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [(0.00)](/filings/0001477932-26-003343.md) | [(0.00)](/filings/0001477932-26-005953.md) | not reported | not reported | [(0.00)](/filings/0001477932-26-003343.md) | [(0.00)](/filings/0001477932-26-005953.md) |
| Basic EPS | $ per share | not reported | not reported | [0.00](/filings/0001477932-25-003941.md) | not reported | not reported | not reported | [(0.00)](/filings/0001477932-26-003343.md) | [(0.00)](/filings/0001477932-26-005953.md) | not reported | not reported | [(0.00)](/filings/0001477932-26-003343.md) | [(0.00)](/filings/0001477932-26-005953.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001477932-23-007965.md) | [0.0](/filings/0001477932-24-003865.md) | [0.0](/filings/0001477932-24-004128.md) | [0.0](/filings/0001477932-24-004867.md) | [0.0](/filings/0001477932-24-007166.md) | [0.0](/filings/0001477932-26-002281.md) | not reported | not reported | [0.0](/filings/0001477932-25-008249.md) | [0.0](/filings/0001477932-26-005953.md) | [0.0](/filings/0001477932-26-003343.md) | [0.2](/filings/0001477932-26-005953.md) |
| Current assets | $m | [0.1](/filings/0001477932-23-007965.md) | [0.1](/filings/0001477932-25-002666.md) | [0.1](/filings/0001477932-24-004128.md) | [0.1](/filings/0001477932-24-004867.md) | [0.0](/filings/0001477932-24-007166.md) | [0.0](/filings/0001477932-26-002281.md) | [0.0](/filings/0001477932-25-003941.md) | [0.0](/filings/0001477932-25-005839.md) | [0.1](/filings/0001477932-25-008249.md) | [0.1](/filings/0001477932-26-005953.md) | [0.1](/filings/0001477932-26-003343.md) | [1.5](/filings/0001477932-26-005953.md) |
| Total assets | $m | [0.1](/filings/0001477932-23-007965.md) | [0.1](/filings/0001477932-25-002666.md) | [0.1](/filings/0001477932-24-004128.md) | [0.1](/filings/0001477932-24-004867.md) | [0.0](/filings/0001477932-24-007166.md) | [0.0](/filings/0001477932-26-002281.md) | [0.0](/filings/0001477932-25-003941.md) | [0.0](/filings/0001477932-25-005839.md) | [10.1](/filings/0001477932-25-008249.md) | [10.5](/filings/0001477932-26-005953.md) | [10.1](/filings/0001477932-26-003343.md) | [26.0](/filings/0001477932-26-005953.md) |
| Current liabilities | $m | [0.3](/filings/0001477932-23-007965.md) | [0.1](/filings/0001477932-25-002666.md) | [0.1](/filings/0001477932-24-004128.md) | [0.2](/filings/0001477932-24-004867.md) | [0.1](/filings/0001477932-24-007166.md) | [0.1](/filings/0001477932-26-002281.md) | [0.1](/filings/0001477932-25-003941.md) | [0.1](/filings/0001477932-25-005839.md) | [7.4](/filings/0001477932-25-008249.md) | [0.2](/filings/0001477932-26-005953.md) | [0.5](/filings/0001477932-26-003343.md) | [14.0](/filings/0001477932-26-005953.md) |
| Total liabilities | $m | [0.3](/filings/0001477932-23-007965.md) | [0.1](/filings/0001477932-25-002666.md) | [0.1](/filings/0001477932-24-004128.md) | [0.1](/filings/0001477932-24-004867.md) | [0.1](/filings/0001477932-24-007166.md) | [0.1](/filings/0001477932-26-002281.md) | [0.1](/filings/0001477932-25-003941.md) | [0.1](/filings/0001477932-25-005839.md) | [7.4](/filings/0001477932-25-008249.md) | [10.4](/filings/0001477932-26-005953.md) | [10.5](/filings/0001477932-26-003343.md) | [27.5](/filings/0001477932-26-005953.md) |
| Shareholders' equity | $m | [(0.2)](/filings/0001477932-23-007965.md) | [(0.0)](/filings/0001477932-26-002281.md) | [(0.0)](/filings/0001477932-24-004128.md) | [(0.0)](/filings/0001477932-24-004867.md) | [(0.0)](/filings/0001477932-24-007166.md) | [(0.0)](/filings/0001477932-26-005953.md) | [(0.1)](/filings/0001477932-25-003941.md) | [(0.1)](/filings/0001477932-25-005839.md) | [2.6](/filings/0001477932-25-008249.md) | [0.0](/filings/0001477932-26-005953.md) | [(0.4)](/filings/0001477932-26-003343.md) | [(1.6)](/filings/0001477932-26-005953.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(103) d](/filings/0001477932-24-007166.md) | [(26.1) d](/filings/0001477932-25-002666.md) | [(75.2)](/filings/0001477932-25-003941.md) | [(128) d](/filings/0001477932-25-005839.md) | [(81.7) d](/filings/0001477932-25-008249.md) | [(56.1) d](/filings/0001477932-26-002281.md) | [(0.8)](/filings/0001477932-26-003343.md) | [0.0 d](/filings/0001477932-26-005953.md) | [7,299 d](/filings/0001477932-25-008249.md) | [(7,338) d](/filings/0001477932-26-002281.md) | [53.8](/filings/0001477932-26-003343.md) | [(1,129) d](/filings/0001477932-26-005953.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [7,108 d](/filings/0001477932-25-008249.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q3 FY2022 (2022-09-30) | Q2 FY2025 (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.8](/filings/0001477932-22-008777.md) | [50.0](/filings/0001477932-22-008777.md) | [83.7](/filings/0001477932-26-005953.md) | [434](/filings/0001477932-26-005953.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 145,991,661 at 2026-09-16, from the cover of the [10-Q/A filed 2026-10-01](/filings/0001477932-26-005953.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.